TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer

This study revealed CRC patients with TTN/OBSCN 'Double-Hit' was significantly associated favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy.PMID:33624434 | DOI:10.1111/jcmm.16393

Source: J Cell Mol Med - February 24, 2021 Category: Molecular Biology Authors: Zaoqu Liu Libo Wang Chunguang Guo Long Liu Dechao Jiao Zhenqiang Sun Kunpeng Wu Yanan Zhao Xinwei Han Source Type: research